Overbeek, J. K., van Erp, N. P., Burger, D. M., den Broeder, A. A., Koolen, S. L. W., Huitema, A. D. R., & ter Heine, R. (2025). Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug Olaparib: Population Pharmacokinetics of Cobicistat and Its use as Pharmacokinetic Booster for Olaparib: J. K. Overbeek et al. Clinical Pharmacokinetics, 64(3), 425. https://doi.org/10.1007/s40262-025-01480-w
Chicago Style (17th ed.) CitationOverbeek, Joanneke K., Nielka P. van Erp, David M. Burger, Alfons A. den Broeder, Stijn L. W. Koolen, Alwin D. R. Huitema, and Rob ter Heine. "Population Pharmacokinetics of Cobicistat and Its Effect on the Pharmacokinetics of the Anticancer Drug Olaparib: Population Pharmacokinetics of Cobicistat and Its Use as Pharmacokinetic Booster for Olaparib: J. K. Overbeek Et Al." Clinical Pharmacokinetics 64, no. 3 (2025): 425. https://doi.org/10.1007/s40262-025-01480-w.
MLA (9th ed.) CitationOverbeek, Joanneke K., et al. "Population Pharmacokinetics of Cobicistat and Its Effect on the Pharmacokinetics of the Anticancer Drug Olaparib: Population Pharmacokinetics of Cobicistat and Its Use as Pharmacokinetic Booster for Olaparib: J. K. Overbeek Et Al." Clinical Pharmacokinetics, vol. 64, no. 3, 2025, p. 425, https://doi.org/10.1007/s40262-025-01480-w.